Alice Goodman | Authors


Prognostic Information in AML Gleaned From Timing of Genetic Mutations

September 02, 2015

A new study suggests that the presence of persistent genetic mutations, 30 days after induction chemotherapy, predicted relapse and survival in patients with acute myeloid leukemia (AML), as well as intermediate-risk patients.

Fewer Moles May Be Related to Aggressive Melanoma

August 21, 2015

It is well known that having multiple moles (ie, >50) is a risk factor for developing melanoma. A new study shows, however, that melanoma can also develop in people with fewer than 50 moles, and when it does, it typically has a more aggressive course.

Robot-Assisted Surgery Shows Good Survival and Less Blood Loss in Bladder Cancer

July 30, 2015

Patients with bladder cancer who undergo robot-assisted radical cystectomy (RARC) appear to have acceptable 5-year survival, according to the largest multi-institutional series to date to collect data on RARC outcomes in this population.

Liquid Biopsies Detect Minimal Residual Disease in Colorectal Cancer

April 29, 2015

Two different types of liquid biopsies—plasma and urine—can detect the number of copies of the KRAS mutation in circulating DNA in patients with colorectal cancer who have resectable liver metastases with near 100% concordance with tissue biopsies, according to a pilot study presented at the 2015 Annual Meeting of the American Association for Cancer Research (AACR).